SEC Form SC 13G filed by MiMedx Group Inc

6/15/22 11:41:37 AM ET

$MDXG

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $MDXG alert in real time by email

SC 13G 1 sc13g12199002_06132022.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

(Amendment No. )¹

MiMedx Group, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

602496101

(CUSIP Number)

June 15, 2022

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐

Rule 13d-1(b)

☒

Rule 13d-1(c)

☐

Rule 13d-1(d)

1 The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 602496101


	1	NAME OF REPORTING PERSON

			Prescience Partners, LP
	2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP				(a) ☐
						(b) ☐

	3	SEC USE ONLY


	4	CITIZENSHIP OR PLACE OF ORGANIZATION

			DELAWARE
NUMBER OF			5	SOLE VOTING POWER
SHARES
BENEFICIALLY					0
OWNED BY			6	SHARED VOTING POWER
EACH
REPORTING					5,719,888
PERSON WITH			7	SOLE DISPOSITIVE POWER

					0
			8	SHARED DISPOSITIVE POWER

					5,719,888
	9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

			5,719,888
	10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES				☐


	11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

			5.0%
	12	TYPE OF REPORTING PERSON

			PN

CUSIP No. 602496101


	1	NAME OF REPORTING PERSON

			Prescience Point Special Opportunity LP
	2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP				(a) ☐
						(b) ☐

	3	SEC USE ONLY


	4	CITIZENSHIP OR PLACE OF ORGANIZATION

			DELAWARE
NUMBER OF			5	SOLE VOTING POWER
SHARES
BENEFICIALLY					0
OWNED BY			6	SHARED VOTING POWER
EACH
REPORTING					1,357,913
PERSON WITH			7	SOLE DISPOSITIVE POWER

					0
			8	SHARED DISPOSITIVE POWER

					1,357,913
	9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

			1,357,913
	10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES				☐


	11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

			1.2%
	12	TYPE OF REPORTING PERSON

			PN

CUSIP No. 602496101


	1	NAME OF REPORTING PERSON

			Prescience Capital, LLC
	2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP				(a) ☐
						(b) ☐

	3	SEC USE ONLY


	4	CITIZENSHIP OR PLACE OF ORGANIZATION

			DELAWARE
NUMBER OF			5	SOLE VOTING POWER
SHARES
BENEFICIALLY					0
OWNED BY			6	SHARED VOTING POWER
EACH
REPORTING					7,077,801
PERSON WITH			7	SOLE DISPOSITIVE POWER

					0
			8	SHARED DISPOSITIVE POWER

					7,077,801
	9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

			7,077,801
	10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES				☐


	11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

			6.2%
	12	TYPE OF REPORTING PERSON

			PN

CUSIP No. 602496101


	1	NAME OF REPORTING PERSON

			Prescience Investment Group, LLC d/b/a Prescience Point Capital Management LLC
	2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP				(a) ☐
						(b) ☐

	3	SEC USE ONLY


	4	CITIZENSHIP OR PLACE OF ORGANIZATION

			LOUSIANA
NUMBER OF			5	SOLE VOTING POWER
SHARES
BENEFICIALLY					0
OWNED BY			6	SHARED VOTING POWER
EACH
REPORTING					7,602,577
PERSON WITH			7	SOLE DISPOSITIVE POWER

					0
			8	SHARED DISPOSITIVE POWER

					7,602,577
	9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

			7,602,577
	10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES				☐


	11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

			6.7%
	12	TYPE OF REPORTING PERSON

			IA

CUSIP No. 602496101


	1	NAME OF REPORTING PERSON

			Eiad Asbahi
	2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP				(a) ☐
						(b) ☐

	3	SEC USE ONLY


	4	CITIZENSHIP OR PLACE OF ORGANIZATION

			UNITED STATES
NUMBER OF			5	SOLE VOTING POWER
SHARES
BENEFICIALLY					0
OWNED BY			6	SHARED VOTING POWER
EACH
REPORTING					7,602,577
PERSON WITH			7	SOLE DISPOSITIVE POWER

					0
			8	SHARED DISPOSITIVE POWER

					7,602,577
	9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

			7,602,577
	10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES				☐


	11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

			6.7%
	12	TYPE OF REPORTING PERSON

			IN

CUSIP No. 602496101

Item 1(a).

Name of Issuer:

MiMedx Group, Inc., a Florida corporation (the “Issuer”).

Item 1(b).

Address of Issuer’s Principal Executive Offices:

1775 West Oak Commons Court, NE,

Marietta, Georgia 30062

Item 2(a).

Name of Person Filing

The names of the persons filing this statement on Schedule 13G (collectively, the “Reporting Persons”) are:

Prescience Partners, LP (“Prescience Partners”),

Prescience Point Special Opportunity LP (“Prescience Point”),

Prescience Capital, LLC (“Prescience Capital”),

Prescience Investment Group, LLC d/b/a Prescience Point Capital Management LLC (“Prescience Management”), and

Eiad Asbahi.

Item 2(b).

Address of Principal Business Office or, if None, Residence

The address of the principal office of each of the Reporting Persons is 1670 Lobdell Avenue, Suite 200, Baton Rouge, Louisiana 70806.

Item 2(c).

Citizenship

Prescience Partners and Prescience Point are each Delaware limited partnerships, Prescience Capital LLC is a Delaware limited liability company, Prescience Management is a Louisiana limited liability company, and Eiad Asbahi is a citizen of the United States of America.

Item 2(d).

Title of Class of Securities:

Common Stock, par value $0.001 per share (the “Common Stock”).

Item 2(e).

CUSIP Number:

602496101

CUSIP No. 602496101

Item 3.

If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

	/x/	Not applicable.

(a)	/ /	Broker or dealer registered under Section 15 of the Exchange Act.

(b)	/ /	Bank as defined in Section 3(a)(6) of the Exchange Act.

(c)	/ /	Insurance company as defined in Section 3(a)(19) of the Exchange Act.

(d)	/ /	Investment company registered under Section 8 of the Investment Company Act.

(e)	/ /	An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).

(f)	/ /	An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).

(g)	/ /	A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).

(h)	/ /	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.

(i)	/ /	A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act.

(j)	/ /	A non-U.S. institution, in accordance with Rule 13d-1(b)(1)(ii)(J).

(k)	/ /	Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: ____

Item 4.

Ownership

(a)

Amount beneficially owned:

As of June 15, 2022:

(i)

Prescience Partners beneficially owns 5,719,888 shares of Common Stock.

(ii)

Prescience Point beneficially owns 1,357,913 shares of Common Stock.

(iii)

As the general partner of each of Prescience Partners and Prescience Point, Prescience Capital may be deemed to beneficially own the 7,077,801 shares of Common Stock held by Prescience Partners and Prescience Point.

(iv)

Prescience Management, as the investment manager and general partner of each of Prescience Partners and Prescience Point, and the investment manager to certain managed accounts (the “Managed Accounts”), may be deemed to beneficially own the 7,602,577 shares of Common Stock held by Prescience Partners, Prescience Point, and the Managed Accounts.

CUSIP No. 602496101

(v)

Eiad Asbahi, as managing member of Prescience Management, may be deemed to beneficially own the 7,602,577 shares held by Prescience Management.

(b)

Percent of class:

The aggregate percentage of Common Stock reported owned by each person named herein is based upon 113,352,746 shares of Common Stock outstanding as of April 27, 2022, which is the total number of shares of Common Stock outstanding as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 3, 2022.

As of June 15, 2022:

(i)

Prescience Partners may be deemed to own approximately 5.0% of the outstanding shares of Common Stock;

(ii)

Prescience Point may be deemed to own approximately 1.2% of the outstanding shares of Common Stock;

(iii)

Prescience Capital may be deemed to beneficially own approximately 6.2% of the outstanding shares of Common Stock;

(iv)

Prescience Management may be deemed to beneficially own approximately 6.7% of the outstanding shares of Common Stock; and

(v)

Eiad Asbahi may be deemed to beneficially own approximately 6.7% of the outstanding shares of Common Stock.

(c)

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote

See Cover Pages Items 5-9.

(ii)

Shared power to vote or to direct the vote

See Cover Pages Items 5-9.

(iii)

Sole power to dispose or to direct the disposition of

See Cover Pages Items 5-9.

(iv)

Shared power to dispose or to direct the disposition of

See Cover Pages Items 5-9.

CUSIP No. 602496101

Item 5.

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the Report Persons have ceased to be the beneficial owners of more than 5 percent of the class of securities, check the following box [ ].

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not Applicable.

Item 7.

Identification and Classification of the Subsidiary That Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable.

Item 8.

Identification and Classification of Members of the Group.

See Exhibit 99.1.

Item 9.

Notice of Dissolution of Group.

Not Applicable.

Item 10.

Certifications.

By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

CUSIP No. 602496101

SIGNATURE

After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Date: June 15, 2022

Prescience Partners, LP

By:	Prescience Point Capital Management LLC Investment Manager

By:	/s/ Eiad Asbahi
	Name:	Eiad Asbahi
	Title:	Managing Member

Prescience Point Special Opportunity LP

By:	Prescience Point Capital Management LLC Investment Manager

By:	/s/ Eiad Asbahi
	Name:	Eiad Asbahi
	Title:	Managing Member

Prescience Capital, LLC

By:	/s/ Eiad Asbahi
	Name:	Eiad Asbahi
	Title:	Managing Member

Prescience Point Capital Management LLC

By:	/s/ Eiad Asbahi
	Name:	Eiad Asbahi
	Title:	Managing Member


/s/ Eiad Asbahi
EIAD ASBAHI

Get the next $MDXG alert in real time by email

Date

Price Target

Rating

Analyst

7/2/2024

$11.00

Overweight

Cantor Fitzgerald

3/7/2024

$12.00

Buy

Lake Street

10/27/2023

$12.00

Buy

Craig Hallum

10/13/2022

$7.00

Buy

Mizuho

9/14/2021

$20.00 → $8.50

Buy

HC Wainwright & Co.

7/26/2021

$23.00

Outperform

Northland Capital

SEC Form SC 13G filed by MiMedx Group Inc

Chat with this insight

Recent Analyst Ratings for $MDXG

$MDXG Press Releases

Fastest customizable press release news feed in the world

MIMEDX to Present at the BofA Securities 2025 Healthcare Conference

MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)

MIMEDX Announces First Quarter 2025 Operating and Financial Results

$MDXG Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Chief Executive Officer Capper Joseph H bought $1,268,000 worth of shares (200,000 units at $6.34), increasing direct ownership by 61% to 529,530 units (SEC Form 4)

Doug Rice bought $35,786 worth of shares (5,000 units at $7.16), increasing direct ownership by 5% to 102,200 units (SEC Form 4)

$MDXG Financials

Live finance-specific insights

MIMEDX Announces First Quarter 2025 Operating and Financial Results

MIMEDX to Host First Quarter 2025 Operating and Financial Results Conference Call on April 30

MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results

$MDXG Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by MiMedx Group Inc